Evaluation of Glutathione Peroxidase and KCNJ11 Gene Polymorphisms in Patients with New Onset Diabetes Mellitus After Renal Transplantation

Abstract

Introduction Genetic mutations such as C599T polymorphism in glutathione peroxidase [GPX1] gene and polymorphisms in potassium channel (KCNJ11) genes have recently been proposed in the etiopathogenesis of new onset diabetes mellitus after renal transplantation (NODAT). We aimed to examine the association of GPX1 and KCNJ11 polymorphisms in NODAT.

Materials and Methods This is a monocenter case-control study with a total of 118 renal transplant recipients who were divided into 2 groups; NODAT and normal glucose tolerance. Relation of GPX1 and KCNJ11 polymorphisms were investigated between these groups. PCR-RFLP method was used for genotyping of polymorphisms in the GPX1 (rs1050450) and KCNJ11 (rs1805127) genes. Two alleles were visualized for each gene (C/T for GPX1 and A/G for KCNJ11).

Results NODAT was correlated with age at transplantation (p<0.001, r=0.380), post-transplant systolic blood pressure (BP) (p=0.02, r=0.211), post-transplant non-HDL cholesterol levels (p=0.01, r=0.803), degree of weight change at the end of the first year (p=0.01, r=0.471), presence of pre-transplant hypertension (HT) (p=0.02, r=0.201), family history of diabetes (p=0.01, r=0.29) and dyslipidemia (p=0.012, r=0.362). GPX1 polymorphism of TT (mutant) allele was significantly more frequent in patients with NODAT (p<0.001, r=0.396) independent from other diabetogenic risk factors. KCNJ11 polymorphisms were similar in both groups and did not show any significant association with NODAT (p=0.10).

Conclusions In addition to several diabetogenic risk factors, C599T polymorphisms in GPX1 gene might also contribute to the development of NODAT. Further studies on larger patient series are necessary in order to reach definitive suggestions.

Key words

GPX1 - KCNJ11 - new onset diabetes mellitus after renal transplantation

• References

• 1 Pham PT, Danovitch GM, Pham SV. Medical management of the kidney transplant recipient. In: Floege J. (ed.). Comprehensive Clinical Nephrology. St. Luis, Missouri: Elsevier Saunders; 2010: 1189-1193
• 2 Chakkera HA, Knowler WC, Devarapalli Y. et al. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am SocNephrol 2010; 5: 1669-1674
• 3 Cole EH, Johnston O, Rose CL. et al. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am SocNephrol 2008; 3: 814-819
• 4 Fuhrer DK, Kobayashi K, Jiang H. Insulin release and suppression by tacrolimus, rapamycin and cyclosporine are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 2001; 3: 393-402
• 5 Kasiske BL, Snyder JJ, Gilbertson D. et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-183
• 6 Cruzado JM, Bestard O, Grinyo JM. Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation. Contrib Nephrol 2012; 176: 108-116
• 7 Johnston O, Rose CL, Webster AC. et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am SocNephrol 2008; 19: 1411-1418
• 8 Chakkera HA, Mandarino LJ. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation 2013; 95: 647-652
• 9 Dutkiewicz G, Domanski L, Pawlik A. et al. Polymorphisms of superoxide dismutase, glutathione peroxidase and catalase genes in patients with post transplant diabetes mellitus. Arch Med Res 2010; 41: 350-355
• 10 Tavira B, Gómez J, Díaz-Corte C. et al. Association between a common KCNJ11 polymorphism (rs5219) and new-onset post transplant diabetes in patients treated with tacrolimus. Mol Genet Metab 2012; 105: 525-527
• 11 Flekac M, Skrha J, Hilgertova J. et al. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008; 9: 30-34
• 12 Gomes MB, Cobas RA. Post-transplant diabetes mellitus. Diabetol Metab Syndr 2009; 1: 14-18
• 13 American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2011; 34: 11-61
• 14 Sever MS. Transplantation steroid impaired glucose metabolism: a hope for improvement?. Nephrol Dial Transplant 2014; 29: 479-482
• 15 Sharma A, Kharb S, Chugh SN. et al. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000; 49: 160-162
• 16 Mysore TB, Shinkel TA, Collins J. et al. Overexpression of glutathione peroxidase with 2 isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes 2005; 54: 2109-2116
• 17 Takeshita S, Inoue N, Ueyama T. et al. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun 2000; 273: 66-71
• 18 Grazyna D, Leszek D, Andrzej P. Polymorphisms of superoxide dismutase, glutathione peroxidase and catalase genes in patients with post-transplant diabetes mellitus. Arch Med Res 2010; 41: 350-355
• 19 Mansego ML, Solar Gde M, Alonso MP. et al. Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens 2011; 29: 492-500
• 20 Malling TH, Sigsgaard T, Andersen HR. et al. Sex determines in the influence of smoking and gene polymorphism on glutathione peroxidase activity in erythrocytes. Scand J Clin Lab Invest 2009; 69: 295-302
• 21 Malling TH, Sigsgaard T, Andersen HR. et al. Sex determines in the influence of smoking and gene polymorphism on glutathione peroxidase activity in erythrocytes. Scand J Clin Lab Invest 2009; 69: 295-302
• 22 Schwanstecher C, Meyer U, Schwanstecher M. K(ir)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP sensitive K(+) channels. Diabetes 2002; 51: 875-879
• 23 Florez JC, Burtt N, de Bakker PI. et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 2004; 53: 1360-1368
• 24 Sakamoto Y, Inoue H, Keshavarz P. et al. SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet 2007; 52: 781-793
• 25 Wang F, Han XY, Ren Q. et al. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin Med J (Engl) 2009; 122: 2477-2482
• 26 Zhou D, Zhang D, Liu Y. et al. The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. Hum Genet 2009; 54: 433-435
• 27 Yang L, Zhou X, Luo Y. et al. Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42.573 individuals. Mol Biol Rep 2012; 39: 645-659
• 28 Scott RA, Langenberg C, Sharp SJ. et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC InterAct study. Diabetologia 2013; 56: 60-69
• 29 Gress TW, Nieto FJ, Shahar E. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: Atherosclerosis risk in communities study. N Engl J Med 2000; 342: 905-912
• 30 Swerdlow DI, Preiss D, Kuchenbaecker KB. et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and body weight: evidence from genetic analysis and randomised trials. Lancet 2015; 385: 351-361
• 31 Collins R, Reith C, Emberson J. et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet (published online on 2016 Sep 8). pii: S0140-6736(16)31357-5 DOI: 10.1016/S0140-6736(16)31357-5.
• 32 Zillich AJ, Garg J, Basu S. et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 219-224